SOMA-MAX-10
Recombinant Human Growth Hormone|10 IU × 10 Vials
SOMA-MAX-10 is a research product containing recombinant human growth hormone (somatropin) produced using recombinant DNA technology.
Each vial contains 10 IU, with 10 vials per kit, providing a total labeled quantity of 100 IU. The packaging identifies the product as Recombinant Human Growth Hormone, Somatropin (rDNA origin) and specifies a 191-amino-acid sequence.
Designed for qualified research and laboratory applications, SOMA-MAX-10 provides researchers with a clearly identified recombinant protein product suitable for controlled experimental workflows.
Product Highlights
About Recombinant Human Growth Hormone
Human growth hormone (GH), also known as somatropin when produced as a recombinant pharmaceutical protein, is a peptide hormone naturally produced by the pituitary gland.
Recombinant human growth hormone is produced using recombinant DNA (rDNA) technology and is designed to correspond to the human growth hormone protein sequence.
Growth hormone biology has been extensively studied because GH participates in signaling pathways involving growth, metabolism, protein synthesis, and the regulation of insulin-like growth factor-1 (IGF-1).
In laboratory research, recombinant GH can be investigated to understand hormone-receptor interactions, cellular signaling, protein biology, and related physiological mechanisms.
Because somatropin is also used clinically in specific approved medical indications, it is important to distinguish research material from an authorized medicinal product.
Product quality, formulation, regulatory status, and permitted applications depend on the specific product and jurisdiction.
Product Specifications
| PRODUCT NAME | SOMA-MAX-10 |
| ACTIVE INGREDIENT | Somatropin |
| DESCRIPTION | Recombinant Human Growth Hormone |
| PRODUCTION | rDNA Origin |
| QUANTITY PER VIAL | 10 IU |
| NUMBER OF VIALS | 10 |
| TOTAL QUANTITY | 100 IU |
| PROTEIN SEQUENCE | 191 amino acids |
| PRODUCT TYPE | Recombinant Protein |
| PHYSICAL FORM | Verify with manufacturer |
| INTENDED APPLICATION | Laboratory / Research Use |
| PACKAGING | 10-vial kit |
| BRAND | Maxtreme Pharma |
Note: The packaging establishes the 10 IU vial strength, 10-vial configuration, 100 IU total, recombinant DNA origin, and 191-amino-acid sequence. Physical form, formulation, purity, excipients, and analytical specifications should be confirmed through the manufacturer's current technical documentation or CoA.
Research Applications
Recombinant human growth hormone is studied extensively in protein, cellular, endocrine, and molecular biology research. Research areas may include:
Researchers may use recombinant GH in controlled experimental systems to investigate hormone activity, receptor signaling, and downstream biological pathways. These research areas describe experimental investigation only and do not constitute approved medical indications or recommendations for human use.
Somatropin Research Profile
Somatropin is recombinant human growth hormone with a protein sequence corresponding to naturally occurring human growth hormone.
Growth hormone exerts its biological effects through interaction with the growth hormone receptor, initiating downstream signaling pathways. One important pathway involves regulation of IGF-1, which plays a significant role in growth and metabolic processes.
Because GH signaling affects multiple biological systems, recombinant somatropin has been investigated in a wide range of experimental models involving cellular signaling, protein metabolism, endocrine biology, and growth-related pathways.
Research findings should not automatically be extrapolated to clinical outcomes or used as a basis for self-administration.
Quality & Packaging
The SOMA-MAX-10 kit contains 10 individually packaged vials, with 10 IU of labeled recombinant human growth hormone per vial, providing a total labeled quantity of 100 IU per kit.
The packaging clearly identifies the product as Recombinant Human Growth Hormone Somatropin (rDNA origin) and specifies the 191-amino-acid sequence.
For professional research procurement, researchers should verify the applicable: Certificate of Analysis (CoA), batch/lot number, protein identity, purity specification, potency/activity assay, analytical testing, formulation information, excipients (if applicable), and storage requirements.
Batch-specific analytical documentation is particularly important for recombinant proteins because identity, purity, potency, and formulation characteristics can vary between products.
Storage & Handling
Store and handle SOMA-MAX-10 according to the manufacturer's batch-specific technical documentation and Certificate of Analysis.
Recombinant proteins can be sensitive to factors such as temperature, light, moisture, agitation, and repeated handling. Appropriate storage conditions depend on the specific formulation and presentation.
Researchers should therefore follow the manufacturer's documented storage and handling requirements rather than relying on generic recommendations. Appropriate laboratory procedures and applicable safety protocols should be followed when handling recombinant human growth hormone.
SOMA-MAX-10 contains recombinant human growth hormone (somatropin).
This product should not be represented as an approved treatment, performance-enhancing product, anti-aging product, or general-purpose growth hormone therapy.
This product is intended only for qualified research and laboratory applications, subject to applicable laws, regulations, institutional requirements, and laboratory safety procedures.
No claim is made that this specific product is safe or effective for the diagnosis, treatment, cure, or prevention of any disease or medical condition.
Not for human consumption or self-administration.
Frequently Asked Questions
SOMA-MAX-10 is a research product containing recombinant human growth hormone (somatropin) produced using recombinant DNA technology.
Each vial contains 10 IU according to the product packaging.
The kit contains 10 vials.
The kit contains 100 IU total, calculated as: 10 vials × 10 IU = 100 IU.
Somatropin is the name commonly used for recombinant human growth hormone produced through recombinant DNA technology.
rDNA means recombinant DNA. It refers to the biotechnology process used to produce the recombinant protein.
The packaging identifies this product as having a 191-amino-acid sequence.
Recombinant human growth hormone is studied in areas including growth hormone receptor signaling, endocrine biology, IGF-1 pathways, protein metabolism, cellular signaling, and recombinant protein research. These research areas do not constitute approved medical applications for this product.
Somatropin is a protein hormone consisting of 191 amino acids. It is commonly discussed alongside peptide hormones, but for a professional catalog, "recombinant protein" or "recombinant human growth hormone" is the more precise classification.
No. The product should be presented as For Research Use Only and not for human consumption or self-administration, subject to applicable laws and regulatory requirements.
Professional research customers should request the applicable Certificate of Analysis (CoA) and batch information, including protein identity, purity, potency/activity, analytical testing, formulation, and storage requirements.